Literature DB >> 1879423

Catabolism of platelet-activating factor and its acyl analog. Differentiation of the activities of lysophospholipase and platelet-activating-factor acetylhydrolase.

A J Aarsman1, F W Neys, H Van den Bosch.   

Abstract

Recent investigations have shown the presence of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine, i.e. the acyl analog of platelet-activating factor (PAF), in unstimulated tissues as well as its formation along with platelet-activating factor upon stimulation of a variety of cells. We demonstrate here that this acyl analog of PAF can be catabolized by purified lysophospholipases I and II from bovine liver with near stoichiometric formation of 2-acetyl-sn-glycero-3-phosphocholine. Lysophospholipase II also deacetylated PAF to lysoPAF and evidence is presented to show that this is an intrinsic activity of this enzyme. This suggested that some lysophospholipases may contribute to intracellular inactivation of PAF by deacetylation. Anion-exchange chromatography of rat liver cytosol confirmed this possibility. However, similar experiments with rat kidney cytosol and rat and human platelet cytosol clearly separated lysophospholipase activities without PAF acetylhydrolase activity from specific PAF acetylhydrolases not having lysophospholipase activity. Thus, lysophospholipases are clearly involved in the metabolism of the acyl analog of PAF and in some tissues, such as liver, may even contribute to abolishing the biological activity of PAF through deacetylation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879423     DOI: 10.1111/j.1432-1033.1991.tb21066.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Determination of phospholipase activity of PAF acetylhydrolase.

Authors:  Diana M Stafforini; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2012-05-29       Impact factor: 7.376

Review 2.  Platelet-activating factor: the biosynthetic and catabolic enzymes.

Authors:  F Snyder
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

3.  Atherosclerosis assessment and rheumatoid arthritis.

Authors:  C Bes; S Gürel; G Buğdaycı; O Dikbaş; M Soy
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

4.  Purification and properties of lysophospholipase isoenzymes from pig gastric mucosa.

Authors:  H Sunaga; H Sugimoto; Y Nagamachi; S Yamashita
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

5.  Group A Streptococcus secreted esterase hydrolyzes platelet-activating factor to impede neutrophil recruitment and facilitate innate immune evasion.

Authors:  Mengyao Liu; Hui Zhu; Jinquan Li; Cristiana C Garcia; Wenchao Feng; Liliya N Kirpotina; Jonathan Hilmer; Luciana P Tavares; Arthur W Layton; Mark T Quinn; Brian Bothner; Mauro M Teixeira; Benfang Lei
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

6.  Altered Lipid Metabolism in Blood Mononuclear Cells of Psoriatic Patients Indicates Differential Changes in Psoriasis Vulgaris and Psoriatic Arthritis.

Authors:  Piotr Wójcik; Michał Biernacki; Adam Wroński; Wojciech Łuczaj; Georg Waeg; Neven Žarković; Elżbieta Skrzydlewska
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

7.  Switching the substrate specificity of lysoplasmalogen-specific phospholipase D.

Authors:  Takayuki Oyama; Kazutaka Murayama; Daisuke Sugimori
Journal:  FEBS Open Bio       Date:  2021-03-19       Impact factor: 2.693

8.  Pathophysiological Alterations of Redox Signaling and Endocannabinoid System in Granulocytes and Plasma of Psoriatic Patients.

Authors:  Ewa Ambrożewicz; Piotr Wójcik; Adam Wroński; Wojciech Łuczaj; Anna Jastrząb; Neven Žarković; Elżbieta Skrzydlewska
Journal:  Cells       Date:  2018-10-06       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.